NCT00618709View on ClinicalTrials.gov

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

ATX-101

ATX-101 single dose

Trial Locations (1)

85283

MDS Pharma Services, Tempe

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY

NCT00618709 - Dose-Escalation Safety and Pharmacokinetic Study of ATX-101 | Biotech Hunter | Biotech Hunter